Stocklytics Platform
Asset logo for symbol DTIL
Precision BioSciences
DTIL73
$5.67arrow_drop_up6.39%$0.33
Penny Stock
Asset logo for symbol DTIL
DTIL73

$5.67

arrow_drop_up6.39%
Key Stats
Open$5.44
Prev. Close$5.32
EPS0.40
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$58.23M
LOWHIGH
Day Range5.32
5.70
52 Week Range3.68
19.43
Ratios
EPS0.40
Fundamentals
Payout Ratio-
Industry average yield2.87%
Last Dividend pay date-
Dividend per share-
Dividend yield forecast-

Stock Analysis

Technicals

Summarizing what the indicators are suggesting.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Analyst rating

An aggregate view of professional's ratings.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Stock Performance

DTIL-
US Healthcare Sector-
US Market-
check_circle

DTIL / Market

DTIL exceeded the US Market which returned 1.35% over the last twenty four hours.
check_circle

DTIL / Healthcare Sector

DTIL exceeded the US Healthcare sector which returned 3.60% over the last twenty four hours.

Precision BioSciences (DTIL) Statistics

Precision BioSciences Inc (DTIL) is a biotechnology company that specializes in genome editing. The company's mission is to improve life through the application of its proprietary ARCUS genome editing platform. Precision BioSciences aims to address the significant challenges in treating genetic diseases by developing precise and efficient genome editing technologies. The company's ARCUS platform utilizes a proprietary enzyme called ARC nuclease to precisely edit genes in vivo or ex vivo. This platform has the potential to revolutionize the field of medicine by enabling the precise correction of genetic mutations.
When it comes to valuation metrics, Precision BioSciences Inc is currently trading at a price-to-earnings ratio (P/E) of -4.38x, which is significantly lower than the industry average of 30.30x. The company's price-to-sales ratio (P/S) is 39.96x, while the price-to-book ratio (P/B) stands at 4.99x. These metrics suggest that the stock may be undervalued compared to its peers in the biotechnology sector.
add Precision BioSciences  to watchlist

Keep an eye on Precision BioSciences

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

How has Precision BioSciences (DTIL) stock's performance compared to its sector and the market over the past year?

Over the past year, Precision BioSciences (DTIL) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 22.20%, Precision BioSciences has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 37.38%, it has fallen short of the market average. This comparison highlights Precision BioSciences 's performance relative to both its sector and the overall market over the last year.
help

What is the PE ratio of Precision BioSciences (DTIL) stock?

The PE (Price to Earnings) ratio of Precision BioSciences (DTIL) is currently 14.19. This metric is used to evaluate the valuation of a company's stock, comparing its current share price relative to its per-share earnings.
help

What is the EPS of Precision BioSciences (DTIL) stock?

The Earnings Per Share (EPS) for Precision BioSciences (DTIL), calculated on a diluted basis, is $0.4. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help

What is the operating margin of Precision BioSciences (DTIL) stock?

The operating margin for Precision BioSciences (DTIL) is -3.69K%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help

What is the EBITDA of Precision BioSciences (DTIL) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Precision BioSciences (DTIL) is -$11.98M. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help

How much debt does Precision BioSciences (DTIL) have?

Precision BioSciences (DTIL) has a total debt of $30.31M. The net debt, which accounts for cash and cash equivalents against the total debt, is -$68.44M.

Take Your Investments to a Whole New Level